BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26035354)

  • 1. Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells.
    Lakshmanan I; Seshacharyulu P; Haridas D; Rachagani S; Gupta S; Joshi S; Guda C; Yan Y; Jain M; Ganti AK; Ponnusamy MP; Batra SK
    Oncotarget; 2015 Aug; 6(25):21085-99. PubMed ID: 26035354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3.
    Ruiz-Saenz A; Dreyer C; Campbell MR; Steri V; Gulizia N; Moasser MM
    Cancer Res; 2018 Jul; 78(13):3645-3658. PubMed ID: 29760043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC4-promoted neural invasion is mediated by the axon guidance factor Netrin-1 in PDAC.
    Wang L; Zhi X; Zhu Y; Zhang Q; Wang W; Li Z; Tang J; Wang J; Wei S; Li B; Zhou J; Jiang J; Yang L; Xu H; Xu Z
    Oncotarget; 2015 Oct; 6(32):33805-22. PubMed ID: 26393880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer.
    Seshacharyulu P; Ponnusamy MP; Rachagani S; Lakshmanan I; Haridas D; Yan Y; Ganti AK; Batra SK
    Oncotarget; 2015 Mar; 6(7):5164-81. PubMed ID: 25686822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway.
    Jahan R; Macha MA; Rachagani S; Das S; Smith LM; Kaur S; Batra SK
    Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2538-2549. PubMed ID: 29777904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer.
    Kaur S; Sharma N; Krishn SR; Lakshmanan I; Rachagani S; Baine MJ; Smith LM; Lele SM; Sasson AR; Guha S; Mallya K; Anderson JM; Hollingsworth MA; Batra SK
    Clin Cancer Res; 2014 Feb; 20(3):688-700. PubMed ID: 24240113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of RNAi-mediated MUC4 gene silencing on the proliferation and migration of human pancreatic carcinoma BxPC-3 cells.
    Li Y; Wu C; Chen T; Zhang J; Liu G; Pu Y; Zhu J; Shen C; Zhang Y; Zeng N; Zhang X
    Oncol Rep; 2016 Dec; 36(6):3449-3455. PubMed ID: 27748843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation.
    Momi N; Ponnusamy MP; Kaur S; Rachagani S; Kunigal SS; Chellappan S; Ouellette MM; Batra SK
    Oncogene; 2013 Mar; 32(11):1384-95. PubMed ID: 22614008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of EHF contributes to thyroid tumorigenesis through transcriptionally regulating HER2 and HER3.
    Lv Y; Sui F; Ma J; Ren X; Yang Q; Zhang Y; Guan H; Shi B; Hou P; Ji M
    Oncotarget; 2016 Sep; 7(36):57978-57990. PubMed ID: 27517321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells.
    Chaturvedi P; Singh AP; Chakraborty S; Chauhan SC; Bafna S; Meza JL; Singh PK; Hollingsworth MA; Mehta PP; Batra SK
    Cancer Res; 2008 Apr; 68(7):2065-70. PubMed ID: 18381409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma.
    Pai P; Rachagani S; Lakshmanan I; Macha MA; Sheinin Y; Smith LM; Ponnusamy MP; Batra SK
    Mol Oncol; 2016 Feb; 10(2):224-39. PubMed ID: 26526617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer.
    Kumar S; Das S; Rachagani S; Kaur S; Joshi S; Johansson SL; Ponnusamy MP; Jain M; Batra SK
    Oncogene; 2015 Sep; 34(37):4879-89. PubMed ID: 25531332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
    Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
    Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
    Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
    Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
    Vasseur R; Skrypek N; Duchêne B; Renaud F; Martínez-Maqueda D; Vincent A; Porchet N; Van Seuningen I; Jonckheere N
    Biochim Biophys Acta; 2015 Dec; 1849(12):1375-84. PubMed ID: 26477488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the splice variant MUC4/Y in the pancreatic cancer cell line MIA PaCa-2 potentiates proliferation and suppresses apoptosis: new insight into the presence of the transcript variant of MUC4.
    Xie K; Zhi X; Tang J; Zhu Y; Zhang J; Li Z; Tao J; Xu Z
    Oncol Rep; 2014 May; 31(5):2187-94. PubMed ID: 24676527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.
    Balz LM; Bartkowiak K; Andreas A; Pantel K; Niggemann B; Zänker KS; Brandt BH; Dittmar T
    J Pathol; 2012 Jun; 227(2):234-44. PubMed ID: 22262199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer.
    Joshi S; Cruz E; Rachagani S; Guha S; Brand RE; Ponnusamy MP; Kumar S; Batra SK
    Mol Oncol; 2016 Aug; 10(7):1063-77. PubMed ID: 27185392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the AMOP domain in MUC4/Y-promoted tumour angiogenesis and metastasis in pancreatic cancer.
    Tang J; Zhu Y; Xie K; Zhang X; Zhi X; Wang W; Li Z; Zhang Q; Wang L; Wang J; Xu Z
    J Exp Clin Cancer Res; 2016 Jun; 35(1):91. PubMed ID: 27287498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy.
    Lee-Hoeflich ST; Crocker L; Yao E; Pham T; Munroe X; Hoeflich KP; Sliwkowski MX; Stern HM
    Cancer Res; 2008 Jul; 68(14):5878-87. PubMed ID: 18632642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.